NUTX Nutex Health Inc
Price (delayed)
$75.06
Market cap
$414.97M
P/E Ratio
7.32
Dividend/share
N/A
EPS
$10.25
Enterprise value
$711.68M
nutex health is a consortium of licensed 24/7 free standing emergency centers. our philosophy is simple: bring concierge level, high quality emergency care to the local community. we build the
Highlights
NUTX's EPS has soared by 199% YoY
The company's gross margin has surged by 192% YoY and by 76% QoQ
The debt has grown by 23% YoY and by 12% from the previous quarter
Key stats
What are the main financial stats of NUTX
Market
Valuations
Earnings
Shares outstanding
5.53M
Market cap
$414.97M
Enterprise value
$711.68M
Price to earnings (P/E)
7.32
Price to book (P/B)
2.79
Price to sales (P/S)
0.85
EV/EBIT
8.22
EV/EBITDA
6.77
EV/Sales
1.48
Revenue
$479.95M
Gross profit
$196.26M
Operating income
$130.62M
Net income
$52.18M
EBIT
$86.59M
EBITDA
$105.18M
Free cash flow
$20.85M
Per share
Balance sheet
Liquidity
EPS
$10.25
EPS diluted
$9.71
Free cash flow per share
$3.83
Book value per share
$26.92
Revenue per share
$88.27
TBVPS
$115.11
Total assets
$655.32M
Total liabilities
$453.43M
Debt
$340.3M
Equity
$146.34M
Working capital
$151.61M
Debt to equity
2.33
Current ratio
2.08
Quick ratio
1.99
Net debt/EBITDA
2.82
Margins
Efficiency
Dividend
EBITDA margin
21.9%
Gross margin
40.9%
Net margin
10.9%
Operating margin
27.2%
Return on assets
10.9%
Return on equity
62.8%
Return on invested capital
13.9%
Return on capital employed
16.8%
Return on sales
18%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NUTX stock price
How has the Nutex Health stock price performed over time
Intraday
5.13%
1 week
33.25%
1 month
36.72%
1 year
434.62%
YTD
136.86%
QTD
59.6%
Financial performance
How have Nutex Health's revenue and profit performed over time
Revenue
$479.95M
Gross profit
$196.26M
Operating income
$130.62M
Net income
$52.18M
Gross margin
40.9%
Net margin
10.9%
The company's gross margin has surged by 192% YoY and by 76% QoQ
Nutex Health's gross profit has surged by 189% QoQ
The net margin has soared by 177% from the previous quarter and by 159% YoY
The revenue has soared by 94% year-on-year and by 64% since the previous quarter
Growth
What is Nutex Health's growth rate over time
Valuation
What is Nutex Health stock price valuation
P/E
7.32
P/B
2.79
P/S
0.85
EV/EBIT
8.22
EV/EBITDA
6.77
EV/Sales
1.48
NUTX's EPS has soared by 199% YoY
NUTX's equity has soared by 142% from the previous quarter and by 138% YoY
The P/B is 121% above the last 4 quarters average of 1.2 but 15% below the 5-year quarterly average of 3.1
The stock's price to sales (P/S) is 170% more than its last 4 quarters average of 0.3 but 61% less than its 5-year quarterly average of 2.1
The revenue has soared by 94% year-on-year and by 64% since the previous quarter
Efficiency
How efficient is Nutex Health business performance
Nutex Health's return on equity has surged by 195% QoQ
Dividends
What is NUTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NUTX.
Financial health
How did Nutex Health financials performed over time
The total assets is 45% greater than the total liabilities
The total assets has surged by 65% year-on-year and by 49% since the previous quarter
Nutex Health's total liabilities has increased by 42% YoY and by 26% QoQ
The debt is 133% more than the equity
NUTX's equity has soared by 142% from the previous quarter and by 138% YoY
The debt to equity has plunged by 54% from the previous quarter and by 48% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.